A pint of sweat will save a gallon of blood: a call for randomized trials of anticoagulation in end-stage renal disease.
From Duke Clinical Research Institute, Durham, NC (C.B.G.); and Stanford University School of Medicine, Stanford University, Stanford, CA (G.M.C.).
Christopher B
CB
Granger
Glenn M
GM
Chertow
D001281:Atrial Fibrillation / Q000453:epidemiology*; D005260:Female; D006470:Hemorrhage / Q000453:epidemiology*; D006801:Humans; D008297:Male; D011159:Population Surveillance; D006435:Renal Dialysis; D020521:Stroke / Q000453:epidemiology*; D014859:Warfarin / Q000009:adverse effects*
D014859:Warfarin
Editorials; atrial fibrillation; end-stage renal disease; randomized controlled trial; stroke